Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Friday, September 30, 2022.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q3 FY2022 (2022-09-30): -384.64%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
N/A
RETURN ON EQUITY (ROE) AVG 3Y
N/A
RETURN ON EQUITY (ROE) AVG 5Y
N/A
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
MiNK Therapeutics, Inc.
Market Cap
$58.91M
Return on Equity (ROE)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$58.97M
Return on Equity (ROE)
N/A
TTM Avg
-866.00%
3Y Avg
-422.47%
5Y Avg
-312.54%
Market Cap
$58.83M
Return on Equity (ROE)
-60.85%
TTM Avg
-77.57%
3Y Avg
-56.89%
5Y Avg
-53.13%
Market Cap
$58.66M
Return on Equity (ROE)
-58.99%
TTM Avg
-51.19%
3Y Avg
-1.82%
5Y Avg
11.74%
Market Cap
$59.97M
Return on Equity (ROE)
-82.38%
TTM Avg
-68.06%
3Y Avg
-60.95%
5Y Avg
-49.61%
Market Cap
$56.65M
Return on Equity (ROE)
N/A
TTM Avg
171.70%
3Y Avg
384.85%
5Y Avg
251.73%
Market Cap
$55.97M
Return on Equity (ROE)
-278.89%
TTM Avg
-162.92%
3Y Avg
25.71%
5Y Avg
0.37%
Market Cap
$55.94M
Return on Equity (ROE)
-132.16%
TTM Avg
-74.56%
3Y Avg
-71.32%
5Y Avg
22.85%
Market Cap
$62.78M
Return on Equity (ROE)
-8.80%
TTM Avg
-13.04%
3Y Avg
-7.69%
5Y Avg
-7.21%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | $58.91M | N/A | N/A | N/A | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $58.97M | N/A | -866.00% | -422.47% | -312.54% |
| Aldeyra The (ALDX)vs › | $58.83M | -60.85% | -77.57% | -56.89% | -53.13% |
| Boundless Bio, Inc. (BOLD)vs › | $58.66M | -58.99% | -51.19% | -1.82% | 11.74% |
| Adicet Bio, Inc. (ACET)vs › | $59.97M | -82.38% | -68.06% | -60.95% | -49.61% |
| Spectral AI, Inc. (MDAI)vs › | $56.65M | N/A | 171.70% | 384.85% | 251.73% |
| eXoZymes, Inc. (EXOZ)vs › | $55.97M | -278.89% | -162.92% | 25.71% | 0.37% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $55.94M | -132.16% | -74.56% | -71.32% | 22.85% |
| InterCure Ltd. (INCR)vs › | $62.78M | -8.80% | -13.04% | -7.69% | -7.21% |
| Apollomics, Inc. (APLM)vs › | $54.90M | N/A | -382.07% | -282.25% | -171.00% |
ROE
N/A
ROA
-118.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2022-09-30 | -384.64% |
| 2022-06-30 | -247.79% |
| 2022-03-31 | -197.27% |
| 2021-12-31 | -127.07% |
